by Lisa Nadal | Nov 28, 2025 | Press Releases, Scientific
Dr. Samuele Cazzamalli, Head of Research at Philochem, will be awarded the Industrial Science Award 2026 from the Swiss Chemical Society His research has focused on the discovery of novel tumor-targeting diagnostic and therapeutic agents through the use of DNA-Encoded...by Lisa Nadal | Oct 1, 2025 | Events, Scientific
Dr. Emanuele Puca will give an oral presentation entitled: “Antibody-cytokine Fusions for Cancer Therapy: Late-Stage Clinical Results” Dr. Roberto de Luca will give an oral presentation entitled: “Engineering Antibody-Cytokine Fusion Proteins (Immunocytokines) for...by Lisa Nadal | Mar 22, 2025 | Events, Scientific
Dr. Sebastian Oehler will present Philochem’s recent discovery in the field of prostate cancer under the title “From DNA-Encoded Chemistry to ACP3-Targeted Radioligand Therapeutics against Prostate Cancer” on May 13th (Radiopharmaceutical Therapies track). Follow the...by Lisa Nadal | Mar 22, 2025 | Events, Scientific
Claudia Comacchio is presenting a poster about Philochem’s ACP3 antibody therapeutics on April 29, entitled “Generation and in vivo characterization of a novel antibody targeting Prostatic Acid Phosphatase (ACP-3)” [Abstract Number 4781]. Gudrun Thorhallsdottir is...by Lisa Nadal | Mar 22, 2025 | Past Events, Scientific
Andrea Galbiati is giving a presentation about Philochem’s FAP-targeted small molecule therapeutics on March 5 (main session), entitled “Detailing Clinical Development of OncoFAP: a Small Molecule Conjugate Targeting Fibroblast Activation Protein in Solid...by Lisa Nadal | Jul 16, 2024 | 2024, Past Events, Scientific
Philochem will participate at the 23rd HUPO Congress in October, presenting two posters: Domenico Ravazza (3rd year Ph.D. student): Mass spectrometry as a quantitative methodology to assess the biodistribution of monoclonal antibodies Lucrezia Principi (2nd year Ph.D....